Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Bacillus coagulans MTCC 5856 and Improved Bowel Movement Frequency

Doses used in studies

spores/day: 2 billion (median 2 billion, IQR 2 billion–2 billion) — 1 study

Safety in these studies

Overall tolerabilityReported
No adverse events or significant changes were observed in clinical parameters throughout the trial period.
from: The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A ra

1 of 1 paper

The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study
- 2023-03-03
- RCT · n = 70
- Medicine 102(9)
- - M. Majeed
  - K. Nagabhushanam
  - Shaji Paulose
  - S. Arumugam
  - Lakshmi A Mundkur
- PubMed: 36862903
- DOI: 10.1097/MD.0000000000033109
14 Insights on
- Improved Bowel Movement Frequency
- High evidence
The Bristol stool type improved to normal in both the groups.
Effect
Neutral
Effect size
Small
Significant
No
Dose
2 billion spores/day